On Oct. 20, 2026 Anthropic said an internal Claude research model designed protein minibinders against scorpion neurotoxins, and that Adaptyv Bio and Twist Bioscience tested 211 designs. Seventeen met Anthropic's binding criteria. Anthropic says it has not tested neutralization in cells or animals and does not claim an antivenom; a participating account also said broader tests flagged some designs as potentially sticky.
/ Sources
/ About this story
Compiled by Venture Atlas from the sources above, using automated AI-assisted research. This is a summary of reporting published elsewhere, not original reporting - follow the source links for the full account. See our editorial standards.
Something wrong here? Email apostructura@gmail.com and we will fix it.
/ Related
- Anthropic commits 5 percent of shares to a public-benefit fundSunday, October 18, 2026
- Anthropic leases EverWind's first Point Tupper data-centre phaseSunday, October 18, 2026
- Claude traces NIST curve seeds to 1997 timestampsSaturday, October 17, 2026
- Claude designs smaller quantum circuits than published bestsSaturday, October 17, 2026